Agilent Technologies, Inc. $A Stock: ProShare Advisors LLC Increases Stake

ProShare Advisors LLC increased its holdings in Agilent Technologies, Inc. (NYSE:A) by 28.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 60,084 shares of the medical research company’s stock after acquiring an additional 13,273 shares during the quarter. ProShare Advisors LLC’s holdings in Agilent Technologies were worth $10,353,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. Investment Research Partners LLC increased its position in Agilent Technologies by 1.8% during the 3rd quarter. Investment Research Partners LLC now owns 3,646 shares of the medical research company’s stock valued at $628,000 after purchasing an additional 63 shares during the period. Greenleaf Trust lifted its position in shares of Agilent Technologies by 0.8% in the 2nd quarter. Greenleaf Trust now owns 8,117 shares of the medical research company’s stock worth $1,078,000 after purchasing an additional 68 shares during the period. Plan A Wealth LLC boosted its stake in shares of Agilent Technologies by 1.9% during the 3rd quarter. Plan A Wealth LLC now owns 3,567 shares of the medical research company’s stock valued at $615,000 after purchasing an additional 68 shares in the last quarter. Nilsine Partners LLC boosted its stake in shares of Agilent Technologies by 0.8% during the 2nd quarter. Nilsine Partners LLC now owns 9,650 shares of the medical research company’s stock valued at $1,282,000 after purchasing an additional 72 shares in the last quarter. Finally, Aspiriant LLC increased its position in shares of Agilent Technologies by 2.0% during the third quarter. Aspiriant LLC now owns 3,786 shares of the medical research company’s stock valued at $652,000 after buying an additional 73 shares during the period.

Insiders Place Their Bets

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the transaction, the director owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on A shares. Citigroup increased their price target on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Piper Sandler lifted their price objective on Agilent Technologies from $150.00 to $160.00 and gave the company a “neutral” rating in a research report on Friday, August 28th. HSBC lifted their price objective on Agilent Technologies from $165.00 to $175.00 and gave the company a “buy” rating in a research report on Tuesday, September 1st. Weiss Ratings upgraded Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Finally, Morgan Stanley increased their target price on Agilent Technologies from $175.00 to $190.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 13th. Eighteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $181.45.

Agilent Technologies Trading Up 2.2%

NYSE:A opened at $175.73 on Wednesday. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $182.99. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The company’s 50-day simple moving average is $164.81 and its 200 day simple moving average is $136.68. The firm has a market capitalization of $49.54 billion, a P/E ratio of 34.59, a PEG ratio of 2.52 and a beta of 1.24.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter last year, the firm earned $1.37 earnings per share. The business’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 6.20 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were given a dividend of $0.2550 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Tuesday, October 6th. Agilent Technologies’s dividend payout ratio (DPR) is 20.08%.

Agilent Technologies Company Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.